TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribetm RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...

New Product Will Help Organizations Align with Evolving Regulatory Landscape on Supply Chain Risk Management LRN Corporation, the leader in ethics and compliance (E&C) solutions that enable organizati ...

Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced the commercial launch of Vyznova® (generic name: neltependocel) in ...

PartnershipLonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) 24.09.2024 / 14:00 CET/CEST Lonza to manufacture CASGEVY®, the world’s first ...

In addition to Dr. Upadhyay’s session, members of Ocugen’s executive team will conduct one-on-one meetings to showcase the Company’s business and clinical development strategy. Details regarding the ...

Discover simple high-yield investing strategies in this article, including overrated and underrated stock picks for potential ...

Metsera, the well-funded obesity biotech from Population Health Partners and ARCH Venture Partners, has unveiled its first ...

Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

I rate Veeva Systems (VEEV) as a buy due to the recent 0.5% interest rate cut from the FED, boosting demand from recovering ...

4. Biotech IPOs: A fall frenzy? When it rains, it pours — IPOs, at least, as another local biotech files paperwork for a ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...